+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Ocular Implants Market - Forecasts from 2021 to 2026

  • ID: 5309017
  • Report
  • March 2021
  • Region: Global
  • Knowledge Sourcing Intelligence LLP

FEATURED COMPANIES

  • AJL Ophthalmic S.A
  • Alcon Vision LLC
  • Alimera Sciences
  • Jardon Eye Prosthetics
  • MORCHER GmbH
  • Ophtec BV
The ocular implants market is estimated to grow at a CAGR of 6.28% to reach US$12.548 billion in 2026 from US$8.192 billion in 2019.



Ocular implants are implantable medical devices that are used to replace the damaged ocular or eye parts and help to restore vision sharpness in humans. Also, these are prosthetic implants that are used to replace the damaged or injured eye. These artificial eye implants are used for the damages caused to the eye due to numerous eye diseases or trauma. Also, the rising prevalence of ophthalmic diseases such as glaucoma, scleritis, uveitis, age-related macular degeneration (AMD) are some of the additional factors supplementing the demand for ocular implants over the next five years. Furthermore, the high prevalence of cataract globally is also anticipated to drive market growth during the coming five years. On the other hand, sedentary lifestyle particularly in the developing economies of the world has further propelled the prevalence of eye disorders since unhealthy lifestyles of the people across these economies have further propelled the number of people suffering from chronic diseases with diabetes being one of them. Since diabetic people often suffer from diabetic retinopathy.

Moreover, the availability of the customized ocular prosthesis as per the patient’s requirement has further played a crucial role in augmenting the demand for ocular implants over the years, thus driving the market growth during the forecast period. Similarly, excessive usage of computers and mobile is leading to eye disorders such as ‘dry eyes’ further leading to the rise in the market. However, complications arising during and after the implantation and the lack of a skilled workforce to perform the procedures are restraining the market during the given time frame. The growing participation by the market players in the form of increased R&D budgets and FDA approvals for new implants and lens delivering technologies further shows the potential for the market over the next five years

The advent of the COVID-19 pandemic is projected to cause a dip in the market growth during the year 2020. The key factor responsible for the declining market is the halt or temporary suspension of elective surgeries in many parts of the world the focus of the healthcare facilities towards the treatment of coronavirus patients increased. Thus, the situation led to a temporary suspension or cancellation of elective surgeries globally, causing a slight decline in the market growth particularly during the short run.

Segmentation
The global ocular implants market has been segmented on the basis of type, End-use, application, and geography. On the basis of type, the classification of the market has been done as intraocular lenses, corneal lenses, ocular prosthesis, and others. By the End-user, the classification of the market has been done into hospitals and clinics and specialty eye hospitals. On the basis of application, the market has been segmented on the basis of intraocular drug delivery, age-related macular degeneration, glaucoma, cataract, and others. Geographically, the distribution of the global market has been done as North America, South America, Europe, Middle East and Africa, and the Asia Pacific.

Globally growing eye-related disorders

The global ocular implants market is projected to witness a substantial growth on account of the globally growing epidemic of eye-related disease and particularly in low or middle-income countries of which uncorrected refractive errors, cataract, age-related macular degeneration, glaucoma, diabetic retinopathy are some of the key disorders being faced by the people. In the United States, around 12 million adults of ages 40 and above suffer from vision impairment of which 1 million are blind, and 8 million have vision impairment due to uncorrected refractive error, and 3 million have vision impairment after correction (Source: U.S Department of Health and Human Services). The department also predicts that by the year 2050 the number of people with uncorrectable vision impairment is projected to reach 8.96 million in which diabetes and other chronic diseases will play a major role. The World Health Organization also predicts that 1 billion people have a near or distance vision impairment that could have been prevented or has yet to be addressed. In conjunction with this, the globally growing geriatric population also supplements the market growth over the course of the next five years

Specialty eye hospitals to hold a prominent share

By End-user, the hospitals and clinics segment is anticipated to show a healthy growth since hospitals are big healthcare institutions that offer specialized treatments under one single roof. The growth in the number of treatments being offered by these facilities coupled with growth in the number of ophthalmic practitioners in super-specialty hospitals further supports the growth of this segment over the next five years. On the other hand, the specialty eye hospitals will hold a prominent share in the market since these facilities offer treatments related to eye disorders only which further leads to high trustworthiness among the patients. Moreover, the presence of numerous specialty eye hospitals in many parts of the world further supplements the significant share of this segment during the next five years

APAC to witness a healthy growth

Geographically, the Asia Pacific region will witness substantial growth over the forecast period which may be attributed to the growing prevalence of eye diseases coupled with the increasing health spending in countries like India and China among others

Competitive Insights

Prominent/major key market players in the global ocular implants market include Ophtec Bphtec BV, Johnson & Johnson Vision Care, Inc., and MORCHER GmbH among others. The players in the global ocular implants market are implementing various growth strategies to gain a competitive advantage over their competitors in this market. Major market players in the market have been covered along with their relative competitive strategies and the report also mentions recent deals and investments of different market players over the last few years. The company profiles section details the business overview, financial performance (public companies) for the past few years, key products and services being offered along with the recent deals and investments of these important players in the global ocular implants market

Segmentation

By Type
  • Intraocular Lenses
  • Corneal Implants
  • Ocular prosthesis
  • Others

By End-use
  • Hospitals and Clinics
  • Specialty Eye Hospitals

By Application
  • Intraocular Drug Delivery
  • Age-Related Macular Degeneration
  • Glaucoma
  • Cataract
  • Others

By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • Spain
  • United Kingdom
  • France
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • Australia
  • India
  • Others

Note: This report will be delivered within 3 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AJL Ophthalmic S.A
  • Alcon Vision LLC
  • Alimera Sciences
  • Jardon Eye Prosthetics
  • MORCHER GmbH
  • Ophtec BV
1. Introduction
1.1. Market Definition
1.2. Market Segmentation

2. Research Methodology
2.1. Research Data
2.2. Assumptions

3. Executive Summary
3.1. Research Highlights

4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. Global Ocular Implants Market Analysis, By Type
5.1. Introduction
5.2. Intraocular Lenses
5.3. Corneal Implants
5.4. Ocular prosthesis
5.5. Others

6. Global Ocular Implants Market Analysis, By End-Use
6.1. Introduction
6.2. Hospitals and Clinics
6.3. Specialty Eye Hospitals

7. Global Ocular Implants Market Analysis, By Application
7.1. Introduction
7.2. Intraocular Drug Delivery
7.3. Age-Related Macular Degeneration
7.4. Glaucoma
7.5. Cataract
7.6. Others

8. Global Ocular Implants Market Analysis, by Geography
8.1. Introduction
8.2. North America
8.2.1. North America Ocular Implants Market, By Type
8.2.2. North America Ocular Implants Market, By End-Use
8.2.3. North America Ocular Implants Market, By Application
8.2.4. By Country
8.2.4.1. United States
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. South America Ocular Implants Market, By Type
8.3.2. South America Ocular Implants Market, By End-Use
8.3.3. South America Ocular Implants Market, By Application
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. Europe Ocular Implants Market, By Type
8.4.2. Europe Ocular Implants Market, By End-Use
8.4.3. Europe Ocular Implants Market, By Application
8.4.4. By Country
8.4.4.1. Germany
8.4.4.2. Spain
8.4.4.3. United Kingdom
8.4.4.4. France
8.4.4.5. Others
8.5. The Middle East and Africa
8.5.1. Middle East and Africa Ocular Implants Market, By Type
8.5.2. Middle East and Africa Ocular Implants Market, By End-Use
8.5.3. Middle East and Africa Ocular Implants Market, By Application
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. Israel
8.5.4.3. Others
8.6. Asia Pacific
8.6.1. Asia Pacific Ocular Implants Market, By Type
8.6.2. Asia Pacific Ocular Implants Market, By End-Use
8.6.3. Asia Pacific Ocular Implants Market, By Application
8.6.4. By Country
8.6.4.1. China
8.6.4.2. Japan
8.6.4.3. Australia
8.6.4.4. India
8.6.4.5. Others

9. Competitive Environment and Analysis
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix

10. Company Profiles
10.1. Ophtec BV
10.2. MORCHER GmbH
10.3. Johnson & Johnson Vision Care, Inc.
10.4. Alimera Sciences
10.5. Jardon Eye Prosthetics
10.6. Bausch & Lomb Incorporated
10.7. Alcon Vision LLC
10.8. Polyactiva Pty Ltd
10.9. AJL Ophthalmic S.A
Note: Product cover images may vary from those shown
  • Ophtec BV
  • MORCHER GmbH
  • Johnson & Johnson Vision Care, Inc.
  • Alimera Sciences
  • Jardon Eye Prosthetics
  • Bausch & Lomb Incorporated
  • Alcon Vision LLC
  • Polyactiva Pty Ltd
  • AJL Ophthalmic S.A
Note: Product cover images may vary from those shown